{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:34Z","timestamp":1789609114198,"version":"build-2803163510"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, and orthostatic hypotension are the most common autonomic disorders encountered in clinical practice. The autoimmune etiology and association of these conditions with systemic autoimmune and inflammatory disorders, autonomic neuropathy, and post-acute infectious syndromes, including Long COVID, suggest that immunotherapies should be considered as a therapeutic option, at least in a subset of patients. However, the treatment of common autonomic disorders has traditionally included pharmacologic and non-pharmacologic symptomatic therapies as the standard approach. Unfortunately, these symptomatic therapies have been of limited or insufficient efficacy to meaningfully improve functional status or result in recovery, especially in patients with severe symptoms. Case reports, case series, and clinical experience suggest that intravenous and subcutaneous immunoglobulin, as well as other immunologic therapies (such as plasmapheresis, corticosteroids, and rituximab), may be effective in some patients with severe POTS and other common autonomic disorders who are refractory to standard therapies. In this narrative review, we summarize the literature available on the topic of immunotherapies for POTS, other common autonomic disorders, and Long COVID. We also highlight the need for large, multicenter, placebo-controlled trials of immunoglobulin, plasmapheresis, intermittent corticosteroids, and other repurposed immunotherapies in patients with common autonomic disorders who have significant functional impairment.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1647203","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:10Z","timestamp":1759123630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction"],"prefix":"10.3389","volume":"15","author":[{"given":"Svetlana","family":"Blitshteyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Funez-dePagnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szombathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","volume-title":"An exploratory, randomized, double-blind placebo-controlled study to assess the safety of an anti-SARS-coV-2 monoclonal antibody and response to treatment in individuals with long COVID (outSMART-LC)","author":"Aerium","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.jacc.2022.04.019","article-title":"Inappropriate sinus tachycardia: etiology, pathophysiology, and management: JACC review topic of the week","volume":"79","author":"Ahmed","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1365-2133.2004.06323.x","article-title":"Guidelines for prescribing azathioprine in dermatology","volume":"151","author":"Anstey","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"B4","unstructured":"Post COVID-19 condition (Long COVID)\n          \n          2022"},{"key":"B5","article-title":"A phase 2 double-blind placebo-controlled single-dose study of pharmacodynamics, pharmacokinetics, safety, and tolerability of REGN7544, an NPR1 antagonist monoclonal antibody","volume-title":"Patients with postural orthostatic tachycardia syndrome","year":"2024"},{"key":"B6","volume-title":"A phase 2 randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of efgartigimod IV in adult patients with post-COVID-19 postural orthostatic tachycardia syndrome (POTS","year":"2022"},{"key":"B7","volume-title":"Long-term follow-up of a randomized multicenter trial on impact of imatinib and infliximab on long-COVID in hospitalized COVID-19 patients","year":"2022"},{"key":"B8","volume-title":"Double-blinded, randomized, sham-controlled trial of immunoadsorption (IA) in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)","year":"2023"},{"key":"B9","volume-title":"A single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-corona virus disease (COVID)-syndrome","year":"2023"},{"key":"B10","volume-title":"RECOVER-AUTONOMIC (IVIG): randomized trial of the effect of IVIG versus placebo on long COVID symptoms","year":"2024"},{"key":"B11","volume-title":"Double-blind, randomized, placebo-controlled phase 3 study evaluating efficacy and safety of igPro20 (Subcutaneous immunoglobulin, HIZENTRA","year":"2024"},{"key":"B12","volume-title":"Randomized double-blind placebo-controlled trial EValuating baricitinib on PERSistent NEurologic and cardiopulmonary symptoms of long COVID (REVERSE-LC","year":"2024"},{"key":"B13","volume-title":"A research trial to find out if tocilizumab helps adults with Long Covid feel better","year":"2025"},{"key":"B14","unstructured":"Immune globulins\n          \n          2023"},{"key":"B15","unstructured":"Prosorba Column Receives FDA Approval for Rheumatoid arthritis treatment"},{"key":"B16","volume-title":"Report no. H970004A","year":"1998"},{"key":"B17","unstructured":"Drug Approval Package: Rayos (prednisone) delayed release ta blet 1 mg, 2 mg, 5 mg\n          \n          2013"},{"key":"B18","volume-title":"Coronavirus (COVID-19) update: FDA revokes emergency use authorization for chloroquine and hydroxychloroquine","year":"2020"},{"key":"B19","article-title":"Adalimumab","volume-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2012"},{"key":"B20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4065\/77.6.531","article-title":"Quality of life in patients with postural tachycardia syndrome","volume":"77","author":"Benrud-Larson","year":"2002","journal-title":"Mayo Clin. Proc."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010166","article-title":"Neuroinflammation at the dorsolateral inferior medulla: A possible central nervous system localization for POTS and long COVID","volume":"13","author":"Blitshteyn","year":"2025","journal-title":"Biomedicines"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1177\/0961203315587566","article-title":"Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS)","volume":"24","author":"Blitshteyn","year":"2015","journal-title":"Lupus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/pmrj.12894","article-title":"Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"14","author":"Blitshteyn","year":"2022","journal-title":"PM R"},{"key":"B24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12026-021-09185-5","article-title":"Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients","volume":"69","author":"Blitshteyn","year":"2021","journal-title":"Immunol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/joim.13245","article-title":"Postural orthostatic tachycardia syndrome is associated with significant employment and economic loss","volume":"290","author":"Bourne","year":"2021","journal-title":"J. Intern. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jneuroim.2018.11.009","article-title":"Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review","volume":"326","author":"Bouxin","year":"2019","journal-title":"J. Neuroimmunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC Guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur. Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/healthcare9111546","article-title":"Back to the future? Immunoglobulin therapy for myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"9","author":"Brownlie","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/art.41528","article-title":"Efficacy and safety of tocilizumab for polyarticular-course juvenile idiopathic arthritis in the open-label two-year extension of a phase III trial","volume":"73","author":"Brunner","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5935\/0004-2749.20190002","article-title":"Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography","volume":"82","author":"Cabral","year":"2019","journal-title":"Arq Bras. Oftalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10286-024-01087-4","article-title":"iSTAND trial of IVIG in POTS: a step in the right direction, but more studies are needed","volume":"35","author":"Chemali","year":"2024","journal-title":"Clin. Auton Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s13311-021-01108-4","article-title":"Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy","volume":"18","author":"Dalakas","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"103710","DOI":"10.1016\/j.autrev.2024.103710","article-title":"Intravenous immunoglobulin as a therapy for autoimmune conditions","volume":"24","author":"Danieli","year":"2025","journal-title":"Autoimmun Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/jpm14080799","article-title":"Long COVID is not a functional neurologic disorder","volume":"14","author":"Davenport","year":"2024","journal-title":"J. Pers. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.18553\/jmcp.2020.26.7.832","article-title":"Indications for rituximab use in an integrated health care delivery system","volume":"26","author":"Delate","year":"2020","journal-title":"J. Manag Care Spec Pharm."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660230","article-title":"Early initiation of tocilizumab treatment against moderate-to-severe myelitis in neuromyelitis optica spectrum disorder","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ehjqcco\/qcae111","article-title":"Impact of COVID-19 Pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome","volume":"11","author":"Dulal","year":"2025","journal-title":"Eur. Heart J. Qual Care Clin. Outcomes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"iqad002","DOI":"10.1093\/oxfimm\/iqad002","article-title":"Autoimmunity in long covid and POTS","volume":"4","author":"El-Rhermoul","year":"2023","journal-title":"Oxf Open Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","article-title":"Long covid defined","volume":"391","author":"Ely","year":"2024","journal-title":"N Engl. J. Med."},{"key":"B41","article-title":"Infliximab","volume-title":"StatPearls","author":"Fatima","year":"2025"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/annrheumdis-2018-214894","article-title":"Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis","volume":"78","author":"Finzel","year":"2019","journal-title":"Ann. Rheum Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/nmo.12391","article-title":"Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility","volume":"26","author":"Flanagan","year":"2014","journal-title":"Neurogastroenterol Motil."},{"key":"B44","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin. Auton Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.19102\/icrm.2018.090702","article-title":"Treatment of neurocardiogenic syncope: from conservative to cutting-edge","volume":"9","author":"Gampa","year":"2018","journal-title":"J. Innov. Card Rhythm. Manag"},{"key":"B47","doi-asserted-by":"publisher","first-page":"109039","DOI":"10.1016\/j.clim.2022.109039","article-title":"Intravenouse immunoglobuline in dysautonomia","volume":"240","author":"Gavrilova","year":"2022","journal-title":"Clin. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mus.27379","article-title":"Non-length-dependent small fiber neuropathy: Not a matter of stockings and gloves","volume":"65","author":"Gemignani","year":"2022","journal-title":"Muscle Nerve"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200195","article-title":"Characterizing acute-onset small fiber neuropathy","volume":"11","author":"Gendre","year":"2024","journal-title":". Neurol. Neuroimmunol Neuroinflamm"},{"key":"B50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/archneurol.2007.60","article-title":"Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy","volume":"65","author":"Gibbons","year":"2008","journal-title":"Arch. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1097\/MJT.0b013e31825e6068","article-title":"Immunoresponsive postinfectious autonomic neuropathy","volume":"21","author":"Goodman","year":"2014","journal-title":"Am. J. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1097\/MJT.0000000000000583","article-title":"Immunoresponsive autonomic neuropathy in sjogren syndrome-case series and literature review","volume":"26","author":"Goodman","year":"2019","journal-title":"Am. J. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5692\/clinicalneurol.cn-001598","article-title":"A case of chronic postural tachycardia syndrome with positive anti-ganglionic acetylcholine receptor (gAChR) antibody","volume":"61","author":"Goto","year":"2021","journal-title":"Rinsho Shinkeigaku"},{"key":"B54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tcm.2021.10.007","article-title":"Postural orthostatic tachycardia syndrome: New concepts in pathophysiology and management","volume":"33","author":"Grubb","year":"2023","journal-title":"Trends Cardiovasc. Med."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013602","article-title":"Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies","volume":"8","author":"Gunning","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/hed.26053","article-title":"Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R\/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study Commence","volume":"42","author":"Ham","year":"2020","journal-title":"Head Neck"},{"key":"B58","article-title":"Methotrexate","volume-title":"StatPearls [Internet]","author":"Hanoodi","year":"2025"},{"key":"B59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.hrcr.2020.11.003","article-title":"Adalimumab as a potential treatment for postural orthostatic tachycardia syndrome","volume":"7","author":"Hendrix","year":"2021","journal-title":"HeartRhythm Case Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archneurol.2010.289","article-title":"Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma","volume":"68","author":"Hollenbeck","year":"2011","journal-title":"Arch. Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2217\/imt-2023-0139","article-title":"Combination of methotrexate with oral disease-modifying antirheumatic drugs in psoriatic arthritis: a systematic review","volume":"16","author":"Hsieh","year":"2024","journal-title":"Immunotherapy"},{"key":"B62","unstructured":"Label: IMATINIB MESYLATE 400 MG- imatinib mesylate tab let, film coated\n          \n          2019"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.bbih.2024.100733","article-title":"Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19","volume":"36","author":"Isman","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJM200010053431404","article-title":"The neuropathic postural tachycardia syndrome","volume":"343","author":"Jacob","year":"2000","journal-title":"N Engl. J. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy - implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat. Rev. Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-256412","article-title":"Primary Sjogren\u2019s syndrome presenting as an isolated severe autonomic dysfunction treated with steroids","volume":"16","author":"Kataria","year":"2023","journal-title":"BMJ Case Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00415-022-11344-z","article-title":"Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS)","volume":"270","author":"Kesterson","year":"2023","journal-title":"J. Neurol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.015989","article-title":"Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome","volume":"9","author":"Kharraziha","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"B70","article-title":"Omalizumab","volume-title":"StatPearls [Internet]","author":"Kumar","year":"2025"},{"key":"B71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nephro.2012.08.002","article-title":"Current indications of azathioprine in nephrology","volume":"9","author":"Ladriere","year":"2013","journal-title":"Nephrol. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4291\/wjgp.v6.i2.33","article-title":"Current therapy of pediatric Crohn\u2019s disease","volume":"6","author":"Lahad","year":"2015","journal-title":"World J. Gastrointest Pathophysiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1012668","article-title":"Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults","volume":"13","author":"Larsen","year":"2022","journal-title":"Front. Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"102841","DOI":"10.1016\/j.autneu.2021.102841","article-title":"Preparing for the long-haul: Autonomic complications of COVID-19","volume":"235","author":"Larsen","year":"2021","journal-title":"Auton Neurosci."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"B76","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.intimp.2018.05.020","article-title":"Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy","volume":"61","author":"Li","year":"2018","journal-title":"Int. Immunopharmacol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0002-9343(90)90173-B","article-title":"A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome","volume":"89","author":"Lloyd","year":"1990","journal-title":"Am. J. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00004691-199301000-00003","article-title":"Autonomic nervous system function","volume":"10","author":"Low","year":"1993","journal-title":"J. Clin. Neurophysiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0165-1838(94)90008-6","article-title":"Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure","volume":"50","author":"Low","year":"1994","journal-title":"J. Auton Nerv Syst."},{"key":"B80","first-page":"S19","article-title":"Postural tachycardia syndrome (POTS)","volume":"45","author":"Low","year":"1995","journal-title":"Neurology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1540-8167.2008.01407.x","article-title":"Postural tachycardia syndrome (POTS)","volume":"20","author":"Low","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1007\/s00415-022-11340-3","article-title":"Nonregional small fibre neuropathy in cases of autoimmune autonomic neuropathy","volume":"269","author":"Maier","year":"2022","journal-title":"J. Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial","volume":"354","author":"Maini","year":"1999","journal-title":"ATTRACT Study Grou Lancet"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e12982","article-title":"Sex adjusted standardized prevalence ratios for celiac disease and other autoimmune diseases in patients with postural orthostatic tachycardia syndrome (POTS): A systematic review and meta-analysis","volume":"9","author":"Mannan","year":"2023","journal-title":"Heliyon"},{"key":"B85","article-title":"Undifferentiated connective tissue disease","volume-title":"StatPearls","author":"Marwa","year":"2025"},{"key":"B86","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N Engl. J. Med."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200244","article-title":"Case-control study of individuals with small fiber neuropathy after COVID-19","volume":"11","author":"McAlpine","year":"2024","journal-title":"Neurol. Neuroimmunol Neuroinflamm"},{"key":"B88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/CRD.0b013e31815c8032","article-title":"Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope","volume":"16","author":"Medow","year":"2008","journal-title":"Cardiol. Rev."},{"key":"B89","first-page":"615","article-title":"Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria","volume":"17","author":"Mosca","year":"1999","journal-title":"Clin. Exp. Rheumatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042296","article-title":"Autoimmune autonomic neuropathy: from pathogenesis to diagnosis","volume":"25","author":"Nakane","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.17226\/27768","volume-title":"A long COVID definition: A chronic, systemic disease state with profound consequences","author":"Fineberg","year":"2024"},{"key":"B92","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.ensci.2020.100276","article-title":"Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report","volume":"21","author":"Novak","year":"2020","journal-title":"eNeurologicalSci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.rmed.2005.10.004","article-title":"Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab","volume":"100","author":"Nowak","year":"2006","journal-title":"Respir. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.bbih.2022.100485","article-title":"Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study","volume":"24","author":"O\u2019Kelly","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"B95","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1007\/s00415-021-10551-4","article-title":"Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies","volume":"268","author":"Oishi","year":"2021","journal-title":"J. Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/europace\/euy128","article-title":"Inappropriate sinus tachycardia","volume":"21","author":"Olshansky","year":"2019","journal-title":"Europace"},{"key":"B97","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/practneurol-2019-002336","article-title":"Plasma exchange in neurological disease","volume":"20","author":"Osman","year":"2020","journal-title":"Pract. Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12883-017-0943-x","article-title":"Acute autonomic neuropathy with severe gastrointestinal symptoms in children: a case series","volume":"17","author":"Pang","year":"2017","journal-title":"BMC Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.14309\/ajg.0000000000002910","article-title":"Joint Hypermobility, Autonomic dysfunction, gastrointestinal dysfunction, and autoimmune markers: clinical associations and response to intravenous immunoglobulin therapy","volume":"119","author":"Pasricha","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/MEG.0000000000000740","article-title":"Is there a relationship between gluten sensitivity and postural tachycardia syndrome","volume":"28","author":"Penny","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: A review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/0002-9343(90)90172-A","article-title":"A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome","volume":"89","author":"Peterson","year":"1990","journal-title":"Am. J. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.jtauto.2021.100112","article-title":"Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome","volume":"4","author":"Pitarokoili","year":"2021","journal-title":"J. Transl. Autoimmun"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cgh.2012.07.006","article-title":"Strategies for the care of adults hospitalized for active ulcerative colitis","volume":"10","author":"Pola","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"E378","DOI":"10.1503\/cmaj.211373","article-title":"Diagnosis and management of postural orthostatic tachycardia syndrome","volume":"194","author":"Raj","year":"2022","journal-title":"CMAJ"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/ene.14711","article-title":"Immunomodulatory treatment in postural tachycardia syndrome: A case series","volume":"28","author":"Rodriguez","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jacep.2016.09.014","article-title":"Ablation of inappropriate sinus tachycardia: A systematic review of the literature","volume":"3","author":"Rodriguez-Manero","year":"2017","journal-title":"JACC Clin. Electrophysiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12967-022-03328-4","article-title":"Autoimmunity is a hallmark of post-COVID syndrome","volume":"20","author":"Rojas","year":"2022","journal-title":"J. Transl. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0022-3956(96)00047-7","article-title":"Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents","volume":"31","author":"Rowe","year":"1997","journal-title":"J. Psychiatr. Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11926-023-01099-5","article-title":"Undifferentiated connective tissue disease: comprehensive review","volume":"25","author":"Rubio","year":"2023","journal-title":"Curr. Rheumatol Rep."},{"key":"B112","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/gerona\/gly188","article-title":"The prevalence of orthostatic hypotension: A systematic review and meta-analysis","volume":"75","author":"Saedon","year":"2020","journal-title":"J. Gerontol A Biol. Sci. Med. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl. J. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/MJT.0000000000000778","article-title":"Intravenous immunoglobulin therapy in refractory autoimmune dysautonomias: A retrospective analysis of 38 patients","volume":"26","author":"Schofield","year":"2019","journal-title":"Am. J. Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/0961203314524468","article-title":"Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS)","volume":"23","author":"Schofield","year":"2014","journal-title":"Lupus"},{"key":"B116","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/WNL.43.1_Part_1.132","article-title":"Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia","volume":"43","author":"Schondorf","year":"1993","journal-title":"Neurology"},{"key":"B117","volume-title":"argenx to unveil its \u2018Vision 2030: Taking Breakthrough Science to 50,000 Patients\u2019 during its Upcoming R&D Day on July 16, 2024","author":"SE","year":"2024"},{"key":"B118","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjmed.2023.01.043","article-title":"Plasma exchange improves cognitive function in long-COVID-related postural orthostatic tachycardia syndrome and autoimmune neurological dysfunction","volume":"138","author":"Seeley","year":"2025","journal-title":"Am. J. Med."},{"key":"B119","article-title":"Plasmapheresis","volume-title":"StatPearls","author":"Sergent","year":"2025"},{"key":"B120","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41584-023-00964-y","article-title":"High risk of autoimmune diseases after COVID-19","volume":"19","author":"Sharma","year":"2023","journal-title":"Nat. Rev. Rheumatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/joim.12895","article-title":"The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey","volume":"286","author":"Shaw","year":"2019","journal-title":"J. Intern. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm."},{"key":"B123","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.clinthera.2024.05.010","article-title":"Successful subcutaneous immunoglobulin therapy in a case series of patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"46","author":"Sjogren","year":"2024","journal-title":"Clin. Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/NRL.0000000000000468","article-title":"Immunotherapy provides electrophysiological recovery and excellent clinical response in sjogren\u2019s syndrome-linked quite severe autonomic neuropathy","volume":"28","author":"Sokmen","year":"2023","journal-title":"Neurologist"},{"key":"B125","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"U.S. Renal Transplant. Mycophenolate Mofetil Study Grou Transplant."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2200970","DOI":"10.1183\/13993003.00970-2022","article-title":"Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms","volume":"61","author":"Son","year":"2023","journal-title":"Eur. Respir. J."},{"key":"B127","unstructured":"Long COVID, household pulse survey, 2022\u20132024\n          \n          2024"},{"key":"B128","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.lanepe.2024.101161","article-title":"Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis\/chronic fatigue syndrome and elevated beta2-adrenergic receptor autoantibodies: a prospective cohort study","volume":"49","author":"Stein","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"B129","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl. J. Med."},{"key":"B130","first-page":"85","article-title":"Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis","volume":"40","author":"Syngle","year":"2015","journal-title":"Acta Reumatol Port"},{"key":"B131","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0025-6196(11)61027-6","article-title":"Postural orthostatic tachycardia syndrome: the Mayo clinic experience","volume":"82","author":"Thieben","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"B132","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.pediatrneurol.2016.06.007","article-title":"Pediatric anti-ganglionic antibody positive autonomic neuropathy: clinical presentation and response to treatment","volume":"64","author":"Tiongson","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/life13061266","article-title":"Efficacy of convalescent plasma to treat long-standing COVID-19 in patients with B-cell depletion","volume":"13","author":"Tomisti","year":"2023","journal-title":"Life (Basel)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2125.2008.03263.x","article-title":"Adalimumab in dermatology","volume":"66","author":"Traczewski","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1177\/1049909119838974","article-title":"Pharmacology update: low-dose naltrexone as a possible nonopioid modality for some chronic, nonmalignant pain syndromes","volume":"36","author":"Trofimovitch","year":"2019","journal-title":"Am. J. Hosp Palliat Care"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.51151","article-title":"Prevalence of post-COVID-19 condition and activity-limiting post-COVID-19 condition among adults","volume":"7","author":"Vahratian","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"B137","doi-asserted-by":"publisher","first-page":"s42","DOI":"10.1191\/0961203305lu2117oa","article-title":"Mycophenolate mofetil and neurological diseases","author":"Vermersch","year":"2005","journal-title":"Lupus"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1212\/01.wnl.0000312280.44805.5d","article-title":"Invited Article: Autonomic ganglia: target and novel therapeutic tool","volume":"70","author":"Vernino","year":"2008","journal-title":"Neurology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"102828","DOI":"10.1016\/j.autneu.2021.102828","article-title":"Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1","volume":"235","author":"Vernino","year":"2021","journal-title":"Auton Neurosci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10286-024-01020-9","article-title":"Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)","volume":"34","author":"Vernino","year":"2024","journal-title":"Clin. Auton Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0002-9343(97)90045-0","article-title":"Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome","volume":"103","author":"Vollmer-Conna","year":"1997","journal-title":"Am. J. Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.jtauto.2021.100100","article-title":"Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms","volume":"4","author":"Wallukat","year":"2021","journal-title":"J. Transl. Autoimmun"},{"key":"B143","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/acn3.524","article-title":"Autoimmune postural orthostatic tachycardia syndrome","volume":"5","author":"Watari","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-221405","article-title":"Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment","volume":"2018","author":"Weinstock","year":"2018","journal-title":"BMJ Case Rep."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.amjmed.2019.10.016","article-title":"Plasma exchange therapy in postural tachycardia syndrome: A novel long-term approach","volume":"133","author":"Wells","year":"2020","journal-title":"Am. J. Med."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008351","article-title":"Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome","volume":"7","author":"Yu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"B147","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s40265-018-0931-5","article-title":"Postural orthostatic tachycardia syndrome: prevalence, pathophysiology, and management","volume":"78","author":"Zadourian","year":"2018","journal-title":"Drugs"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1647203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:18Z","timestamp":1759123638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1647203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":147,"alternative-id":["10.3389\/fcimb.2025.1647203"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1647203","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1647203"}}